Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma.
In: Nature Communications, Jg. 15 (2024-04-01), Heft 1, S. 1-22
academicJournal
Zugriff:
Osteosarcoma is the most common primary malignant bone tumor with a strong tendency to metastasize, limiting the prognosis of affected patients. Genomic, epigenomic and transcriptomic analyses have demonstrated the exquisite molecular complexity of this tumor, but have not sufficiently defined the underlying mechanisms or identified promising therapeutic targets. To systematically explore RNA-protein interactions relevant to OS, we define the RNA interactomes together with the full proteome and the transcriptome of cells from five malignant bone tumors (four osteosarcomata and one malignant giant cell tumor of the bone) and from normal mesenchymal stem cells and osteoblasts. These analyses uncover both systematic changes of the RNA-binding activities of defined RNA-binding proteins common to all osteosarcomata and individual alterations that are observed in only a subset of tumors. Functional analyses reveal a particular vulnerability of these tumors to translation inhibition and a positive feedback loop involving the RBP IGF2BP3 and the transcription factor Myc which affects cellular translation and OS cell viability. Our results thus provide insight into potentially clinically relevant RNA-binding protein-dependent mechanisms of osteosarcoma. Proteomic, transcriptomic, and genomic analysis has shown osteosarcoma (OS) to be a complex and heterogenous disease but revealed little about its carcinogenesis or potential therapeutic targets. Here, the authors profile the RNA interactome, transcriptome and proteome of cells derived from OS patients, identifying a targetable vulnerability to translation inhibition. [ABSTRACT FROM AUTHOR]
Copyright of Nature Communications is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma.
|
---|---|
Autor/in / Beteiligte Person: | Zhou, Yang ; Ray, Partho Sarothi ; Zhu, Jianguo ; Stein, Frank ; Rettel, Mandy ; Sekaran, Thileepan ; Sahadevan, Sudeep ; Perez-Perri, Joel I. ; Roth, Eva K. ; Myklebost, Ola ; Meza-Zepeda, Leonardo A. ; von Deimling, Andreas ; Fu, Chuli ; Brosig, Annika N. ; Boye, Kjetil ; Nathrath, Michaela ; Blattmann, Claudia ; Lehner, Burkhard ; Hentze, Matthias W. ; Kulozik, Andreas E. |
Zeitschrift: | Nature Communications, Jg. 15 (2024-04-01), Heft 1, S. 1-22 |
Veröffentlichung: | 2024 |
Medientyp: | academicJournal |
ISSN: | 2041-1723 (print) |
DOI: | 10.1038/s41467-024-47031-y |
Schlagwort: |
|
Sonstiges: |
|